Free tool
Stocks listed on Stockholm
We cover 37 companies listed on Stockholm. The median market value in the group is $350.23M. Across the group, the median move over the past trading day is +0.69%. 54% of the 37 with a 200-day average trade above it. Price change over the past year runs from −63.6% to +43.7% across the middle 80 percent of the group, with a median of −17.0%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
37 of 928 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% | Oct 30, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% | Oct 22, 2026 |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% | Nov 6, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% | Oct 22, 2026 |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% | Oct 29, 2026 |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% | Nov 4, 2026 |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% | Oct 22, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% | Oct 22, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% | Oct 22, 2026 |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% | Nov 12, 2026 |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% | Oct 23, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% | Oct 21, 2026 |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% | Nov 5, 2026 |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% | Oct 22, 2026 |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% | Nov 3, 2026 |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% | Nov 5, 2026 |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% | Oct 28, 2026 |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% | Nov 6, 2026 |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% | Oct 22, 2026 |
| VICO.ST | Vicore Pharma Holding AB (publ) | $315.07M | Small cap | −1.29% | Nov 5, 2026 |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% | Nov 12, 2026 |
| BINV.ST | BioInvent International AB (publ) | $162.35M | Small cap | −23.46% | Aug 27, 2026 |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% | Nov 11, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | $132.45M | Small cap | −22.05% | Oct 22, 2026 |
| MVIR.ST | Medivir AB (publ) | $131.70M | Small cap | +4.73% | Nov 5, 2026 |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% | Nov 3, 2026 |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% | Nov 11, 2026 |
| ONCO.ST | Oncopeptides AB (publ) | $68.14M | Micro cap | −67.92% | Aug 27, 2026 |
| SEZI.ST | Senzime AB (publ) | $61.48M | Micro cap | −39.98% | Oct 29, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $52.93M | Micro cap | −46.25% | Oct 22, 2026 |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% | Nov 25, 2026 |
| ORX.ST | Orexo AB (publ) | $48.90M | Micro cap | −35.06% | Oct 22, 2026 |
| OSSD.ST | OssDsign AB (publ) | $44.89M | Micro cap | −73.26% | Nov 3, 2026 |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% | Nov 12, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| VIVE.ST | Vivesto AB | $10.39M | Micro cap | −57.13% | Nov 12, 2026 |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | $3.19M | Micro cap | −93.99% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.